Striatal dopamine transporter binding assessed by [I-123]IPT and single photon emission computed tomography in patients with early Parkinson's disease: Implications for a preclinical diagnosis

Archives of Neurology

Volumn 57, Issue 2, 2000, Pages 205-208

  Schwarz, Johannes ^a,e   Linke, Rainer ^b   Kerner, Martina ^b   Mozley, P David ^c   Trenkwalder, Claudia ^d   Gasser, Thomas ^b   Tatsch, Klaus ^b  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^e CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE TRANSPORTER; TROPANE DERIVATIVE;

ADULT; AGED; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; HUMAN; MAJOR CLINICAL STUDY; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOMATOLOGY;

EID: 0033982104     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.57.2.205     Document Type: Article

References (17)

1. Nirenberg MJ, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci. 1996;16:436-447.
2. Innis RB, Seibyl JP, Scanley BE, et al. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson's disease. Proc Natl Acad Sci U S A. 1993;90:11965-11969.
3. Kuikka JT, Bergström KA, Vanninen E, Laulumaa V, Hartikainen P, Länsimies E. Initial experience with single-photon emission tomography using iodine-123-labelled 2β-carbomethoxy-3β-(4-iodophenyl)tropane in human brain. Eur J Nucl Med. 1993;20:783-786.
4. 123I]-CIT SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease. Neurology. 1996;46:231-237.
5. 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann Neurol. 1993;34:423-431.
6. Schwarz J, Tatsch K, Linke R, Pogarell O, Mozley O, Kung HF. Measuring the decline of dopamine transporter binding in patients with Parkinson's disease using 123I-IPT and SPECT [abstract]. Neurology. 1997;48:A208.
7. Marek KL, Seibyl J, Fussell B, Cellar J, Smith E, Innis B. 123I β-CIT: assessment of progression in Parkinson's disease [abstract]. Neurology. 1997;48:A207.
8. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatr. 1992;55:181-184.
9. Mozley PD, Kim HJ, Gur RC, et al. Iodine-123-IPT SPECT imaging of the CNS dopamine transporters: nonlinear effects of normal aging on striatal uptake values. J Nucl Med. 1996;37:1965-1970.
10. Kung M-P, Essmann WD, Frederick D, et al. IPT: a novel iodinated ligand for the CNS dopamine transporter. Synapse. 1995;20:316-324.
11. Mozley PD, Stubbs JB, Kim H-J, et al. Dosimetry of an iodine-123-labeled tropane to image dopamine transporters. J Nucl Med. 1996;37:151-159.
12. Tatsch K, Schwarz J, Mozley PD, et al. Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [I-123]IPT and SPECT. Eur J Nucl Med. 1997;24:415-421.
13. 18F]dopa metabolism in the striatum in Parkinson's disease. Brain. 1996;119:2097-2103.
14. Donnan GA, Woodhouse DG, Kaczmarczyk SJ, et al. Evidence for plasticity of the dopaminergic system in parkinsonism. Mol Neurobiol. 1991;5:421-433.
15. 11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease: implications for the symptomatic threshold. Neurology. 1997;48:1578-1583.
16. Booij J, Tissingh G, Boer GJ, et al. [I-123]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. J Neurol Neurosurg Psychiatry. 1997;62:133-140.
17. Rinne JO, Laihinen, A, Nagren K, Ruottinen H, Ruotsalainen U, Rinne UK. PET examination of the monoamine transporter with [C-11]β-CIT and [C-11]β-CFT in early Parkinson's disease. Synapse. 1995;21:97-103.